Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Erik‐Jan van den Dool"'
Autor:
Laura M. Willemsen, Eline A. Vlot, Paul W. A. Janssen, Claire D. Visser, Kai Zheng, Johannes C. Kelder, Peter G. Noordzij, Erik‐Jan van den Dool, Patrick Klein, Christian M. Hackeng, Jurrien M. ten Berg
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 8, Pp n/a-n/a (2021)
Abstract Background Aspirin is important for preventing thrombotic events but also increases bleeding complications. Minimizing bleeding while preventing thrombotic events remains challenging in patients undergoing coronary artery bypass grafting (CA
Externí odkaz:
https://doaj.org/article/44e61c504d7449bbb67208104edc6fe6
Autor:
Y. Whitney Cheung, Mireille J. Serlie, Saskia Middeldorp, Michiel Coppens, Stefano Barco, Erik-Jan van den Dool, Ron A. A. Mathôt, An K. Stroobants
Publikováno v:
Thrombosis research, 160, 76-82. Elsevier Limited
Background and aims: Patients on parenteral nutrition for short bowel syndrome (SBS) have a high risk of thrombotic complications and are often treated with parenteral anticoagulation. Direct oral anticoagulants are absorbed proximally in the digesti
Autor:
Marion Heckman, Willem van Dam, C. Ağar, An K. Stroobants, Willem J. Schornagel, Bianca Bakker, Auguste Sturk, Prim de Bie, Erik-Jan van den Dool
Publikováno v:
Thrombosis research, 131(4), 357-362. Elsevier Limited
Introduction The Coasys® Plus C (Behnk Elektronik, distributed by Roche Diagnostics) is a coagulation analyzer for small to midsize clinical chemistry laboratories. We performed a laboratory evaluation. Materials and Methods After a familiarization
Autor:
Daan van de Kerkhof, Volkher Scharnhorst, Joyce Curvers, An K. Stroobants, Erik-Jan van den Dool
Publikováno v:
American Journal of Clinical Pathology. 138:551-558
The use of direct thrombin inhibitors (DTIs) for prophylactic or therapeutic anticoagulation is increasing because of the predictable bioavailability and short half-life of these DTIs. However, in certain situations, indication of the concentration i
Autor:
An K. Stroobants, Daan van de Kerkhof, Michiel Coppens, Saskia Middeldorp, Erik Jan van den Dool, Stefano Barco
Publikováno v:
Thrombosis and haemostasis, 112(4), 836-838. Schattauer GmbH
Successful co-administration of dabigatran etexilate and protease inhibitors ritonavir/lopinavir in a patient with atrial fibrillation
Autor:
René M. Vos, Abraham J. Wilhelm, Erik-Jan van den Dool, Yvonne van der Heide, Sandra Huissoon, Jurjen S. Lagas, Desiderius P M Brandjes, Jos H. Beijnen
Publikováno v:
Human & experimental toxicology, 30(1), 74-78. SAGE Publications Inc.
Lagas, J S, Wilhelm, A J, Vos, R M, van den Dool, E J, van der Heide, Y, Huissoon, S, Beijnen, J H & Brandjes, D P M 2011, ' Toxicokinetics of a dipyridamole (Persantin) intoxication: Case report ', Human & Experimental Toxicology, vol. 30, no. 1, pp. 74-78 . https://doi.org/10.1177/0960327110368696
Human & Experimental Toxicology, 30(1), 74-78. SAGE Publications Inc.
Lagas, J S, Wilhelm, A J, Vos, R M, van den Dool, E J, van der Heide, Y, Huissoon, S, Beijnen, J H & Brandjes, D P M 2011, ' Toxicokinetics of a dipyridamole (Persantin) intoxication: Case report ', Human & Experimental Toxicology, vol. 30, no. 1, pp. 74-78 . https://doi.org/10.1177/0960327110368696
Human & Experimental Toxicology, 30(1), 74-78. SAGE Publications Inc.
We report a case of a 51-year-old woman who was admitted to the hospital after ingestion of large doses of dipyridamole (12 g), temazepam (1 g) and oxazepam (0.2 g) with suicidal intent. The highest dipyridamole concentration that was measured in ser
Autor:
Joyce, Curvers, Daan, van de Kerkhof, An K, Stroobants, Erik-Jan, van den Dool, Volkher, Scharnhorst
Publikováno v:
American journal of clinical pathology. 138(4)
The use of direct thrombin inhibitors (DTIs) for prophylactic or therapeutic anticoagulation is increasing because of the predictable bioavailability and short half-life of these DTIs. However, in certain situations, indication of the concentration i
Publikováno v:
Journal of pediatric hematology/oncology, 30(3), 230-234. Lippincott Williams and Wilkins
Low-molecular-weight heparins are increasingly used for treatment of pediatric venous thromboembolic disease (VTE). Pediatric data about therapeutic doses of nadroparin are not available. To evaluate pharmacodynamics and safety of therapeutic doses o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4407a630ca47e99b963d0a8562afe8a2
https://pure.amc.nl/en/publications/nadroparin-therapy-in-pediatric-patients-with-venous-thromboembolic-disease(440b9b27-a81b-440b-bf0a-6ceb454d6838).html
https://pure.amc.nl/en/publications/nadroparin-therapy-in-pediatric-patients-with-venous-thromboembolic-disease(440b9b27-a81b-440b-bf0a-6ceb454d6838).html